We’re a biotech company founded in 2020 to discover and develop next-generation allogeneic cell therapies for cancer patients.
Just as the first Roman aqueduct Aqua Appia was a highly sophisticated feat of engineering built to serve more people, so too is our cellular technology platform - ACUA.
Our mission is to create novel, curative, and accessible cell therapies for patients.
Our vision is to be the leading cell therapy company transforming patients' lives through the passionate pursuit of innovation and excellence.
Meet our team
Leadership team
Jeff Wiezorek, MD
Chief Medical Officer, FounderSylvaine Cases, PhD
Chief Business OfficerQi Wei, PhD
Senior Vice President, Technical OperationsDavid Morse
Vice President, QualityAlex Babayan, PhD
Vice President, RegulatoryBoard of directors
David Baltimore, PhD
Board Chairman, Founder, President Emeritus of CaltechDaqing (Darren) Cai, PhD
Managing Partner, Sherpa Healthcare PartnersMargo Roberts, PhD
Former CSO of Kite Pharma and Lyell ImmunopharmaScientific Founders and Advisory board
David Baltimore, PhD
Board Chairman, Founder, President Emeritus of CaltechAntoni Ribas, MD, PhD
Professor of medicine, UCLA, and director of the tumor immunology program, Jonsson comprehensive cancer centerMargo Roberts, PhD
Former CSO of Kite Pharma and Lyell ImmunopharmaIrving Weissman, MD
Professor and Director of the Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
